Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 587,500 shares, an increase of 7.4% from the April 15th total of 547,200 shares. Currently, 2.7% of the company’s shares are short sold. Based […]
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) – Equities researchers at HC Wainwright decreased their FY2024 earnings per share (EPS) estimates for shares of Eton Pharmaceuticals in a research note issued to investors on Friday, May 12th. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn $0.15 per share for the year, […]
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) saw a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 587,500 shares, an increase of 7.4% from the April 15th total of 547,200 shares. Approximately 2.7% of the shares of the company are short sold. Based on […]
Operator: Good afternoon and welcome to the Eton Pharmaceuticals First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen only mode.
Product sales and royalty revenue of $5.3 million up 144% from Q1 2022 and 52% from Q4 2022Launched Betaine AnhydrousManagement to hold conference call today at 4:30pm ET DEER PARK, Ill., May 11,. | May 11, 2023